Dr. David Chiu is Medical Director of the Houston Methodist Hospital Eddy Scurlock Stroke Center in Houston and Neurologist at the Methodist Neurological Institute.
His active clinical practice benefits from his extensive translational research in extending the time and quality of life for stroke patients, acute stroke treatment, stroke prevention in those who have experienced Transient Ischemic Attack (TIA) and stroke.
He serves on the board of directors for the American Heart Association and is an active member of the American Academy of Neurology, American Heart Association Stroke Council, Texas Medical Association and Harris County Medical Association. He is also a reviewer for Stroke and Journal of Neurology, Neurosurgery and Psychiatry. Dr. Chiu is Associate Professor of Clinical Neurology at the Weill Medical College of Cornell University He received his M.D. from Yale University School of Medicine. He completed his residency in neurology at the University of California at San Francisco and his fellowship in cerebrovascular disease at University of Texas at Houston School of Medicine.
- Arteriovenous malformation
- Atrial septum defect
- Carotid endarterectomy
- Neuro-Vascular surgery
- Stroke rehabilitation
- Thrombolysis and neuroprotection in stroke
- Clinical trials in stroke treatment and prevention
- Outcomes and epidemiology of stroke
- Cardiovascular and ECG sequelae of stroke
- Radiographic findings in stroke
- Risk factor treatment
- Stroke prevention
Education & Training:
M.D. Yale University School of Medicine
Neurology Residency, University of California at San Francisco School of Medicine
Fellowship in Cerebrovascular Disease, the University of Texas Houston Medical School
Neurology, American Board of Psychiatry and Neurology
Neurology Recertification, American Board of Psychiatry and Neurology
Vascular Neurology, American Board of Psychiatry and Neurology
- Fiorella D, Derdeyn CP, Lynn MJ, Barnwell SL, Hoh BL, Levy EI, Harrigan MR, Klucznik RP, McDougall CG, Pride GL, Zaidat OO, Lutsep HL, Waters MF, Hourihane JM, Alexandrov AV, Chiu D, Clark JM, Johnson MD, Torbey MT, Rumboldt Z, Cloft HJ, Turan TN, Lane BF, Janis LS, Chimowitz MI. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS). Stroke 2012:43:2682-2688.
- Lal BK, Beach KW, Roubin GS, Lutsep HL, Moore WS, Malas MB, Chiu D, Gonzales NR, Burke JL, Rinaldi M, Elmore JR, Weaver FA, Narins CR, Foster M, Hodgson KJ, Shepard AD, Meschia JF, Bergelin RO, Voeks JH, Howard G, Brott TG, for the CREST Investigators. Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol 2012:11:755-763.
- The ARISTOTLE Investigators. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol 2012:11:503-511
- The CLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. NEJM 2012:366:991-999.
- Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ for the SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. NEJM 2011:365:993-1003.